Our TeamSpine Center Research
Actively enrolling and upcoming studies
| Sponsor | Title | Site | Eligibility |
PI/Co-PI |
| Globus, Inc | Does the type of procedure affect the incidence of dysphagia and dysphonia in ACDF patients? | Cervical |
One level ACDF Radomized Trial of Globus Coalition vs Colonial + Providence using Autogenious Bone Material |
Kim |
| Mesoblast | MSB-CF002 Multi-level ACDF using NeoFuse with MasterGraft. Phase 1b/2a | Cervical |
Two or three level ACDF Randomized Trial of NeoFuse (MPC's) plus Mastergraft Matrix vs cervical allograft spacer control |
Kim/Klineberg |
| Mesoblast | MSB-DR003 Lumbar Disc Rengeration Study | Lumbar |
Chronic low back pain > 6 months due to DDD at one level L1 to S1 and failed three months of conservative therapy Randomized trial of single injetion of MPC's (high dos vs low dose) combined with hyaluronic acid (HA) vs. control injection (HA vs. saline) into symptomatic disc |
Kim/Scott Fishman |
| Lanx, Inc. | Randomized study of ASPEN (R) Spinous Process System vs Pedicle screws in ALIF | Lumbar |
One level ALIF with posterior fixation Randomized Trial of Aspen vs Pedicle screws |
Kim |
| AOSpine | Efficacy of Riluzole in Patient with Cerical Spondylotic Myelopathy Undergoing Surgical Treatment | Cervical |
Cervical myelopathy undergoing surgical decompression Randomized trial of Riluzole, 50 mg bid vs placebo 14 days prior to surgery through 28 days postop. |
Kim/Klinesberg |
| Covidien | DuraSeal Exact Spine Sealant Post-Approval Study | Dural openings |
Planned or incidental dural openings Prospective: planned or incidental use of DuraSeal Exact during surgery |
Kim/Boggan |
| Asubio-SUN | SUN13837 Injection for acute spinal cord injury | Cervical |
Closed single traumatic SCI between C4 through C7. Must receive first dose of druge within 12 hours of injury. Randomized trial of SUN13837 injection vs placebo x 28 days. |
Kim/Klineberg |
Updated October 2012
